Avalere | The intersection of business strategy and public policy
Home About Avalere Health Research Portfolio News Services Events Staff Contact Us

Forum on Diabetes / Broaden Your View.  March 12-13, 2008 | Washington, DC

Avalere Health is proud to have assembled a diverse group of leaders and decision-makers in government, industry, and advocacy. These key players will engage you and each other in a dialogue on the current and future state of diabetes care in the United States. Broaden your view with the insights of these speakers at the Avalere Health Forum on Diabetes.

Speaker Profiles /

Ann Albright | John E. Anderson | Bob Atlas | Jan Berger | Jonathan Blum |
Jennifer Bowman | Perry Bridger | Carolyn M. Clancy | Keith J. Fontenot |
Judith E. Fradkin | Jon Glaudemans | Marsha Gold | Amparo Gonzalez |
Jennifer Hersh | Shannah Koss | Dan Mendelson | Joe Quinn | Jim Schlicht |
Joshua Seidman | Jaan Sidorov | Linda Siminerio | Lawrence A. Soler

 

Jon Glaudemans, Senior Vice President, directs Avalere’s day-to-day operational management and consults on a wide array of Medicare, Medicaid, and hospital/plan issues.  Jon has more than 25 years of senior leadership experience in health insurance, managed care, policy issues management, and public affairs.  In his various professional engagements, Jon has worked closely with boards of directors, hospital chief executive officers, and key corporate and public sector leaders to develop and implement business strategies and public policy reforms designed to improve healthcare delivery and financing at the national, state, and local levels.

Most recently, Jon was Managing Director of the Washington, DC, office of the Austin, Texas-based firm, Public Strategies, a leading public affairs firm specializing in developing and executing board- and senior-management strategies to manage public policy threats and opportunities.  At Public Strategies, Jon’s clients included leading healthcare, financial, and technology companies.  His work spanned the spectrum of deep substantive analyses, new corporate business strategies, targeted communications and grassroots campaigns, and government relations work.  

Prior to joining Public Strategies, Jon served as the Transition Coordinator to the then-incoming Administrator of the U.S. Health Care Financing Administration/CMS, where he was intimately involved in developing the White House policies to advance President George W. Bush’s prescription drug coverage and pro-competition objectives.  He also led the development and initial roll out of the President’s proposed Prescription Drug Discount Card Program – and played a central role in achieving the broad government-private sector consensus on the program’s specifics and subsequent industry participation.

Previously, Jon spent 10 years at Aetna, where his leadership in progressively responsible positions included General Manager of Aetna U.S. Healthcare’s Capital Region and Vice President for Strategic Planning and Business Development.  In his role at Aetna, Jon worked with the Jackson Hole Group and others in developing pro-competition policies to expand coverage and manage healthcare spending, and played a visible and central role in Aetna’s efforts to increase its visibility and influence in the healthcare policy debates. He also led the company’s initial strategic and due diligence activities that ultimately culminated in three substantial acquisitions over the 1995-7 period.

Jon began his career at the U.S. Office of Management and Budget (OMB), where he spent nine years working on a variety of public health, Medicaid, and Medicare policy issues.  During his time at OMB, he and his area worked on such seminal health policy issues as the introduction of hospital prospective payment, the adoption of RB-RVS and physician spending targets, and the first effort to extend prescription drug coverage to Medicare beneficiaries.

Jon holds a B.A. in Political Science from M.I.T. and a M.P.A. in Economics from Princeton University.

 

 

Introduction
Agenda
Registration
 Speaker Profiles
Research
Sponsors and Partners